Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study tests a simpler low disease activity measure for lupus

Key clinical point: A simpler disease activity scale could boost treat-to-target efforts in patients with systemic lupus erythematosus.

Major finding: There was no significant difference in how the new index, the systemic lupus erythematosus Disease Activity Score, and the Lupus Low Disease Activity State performed in classifying patients as having low disease activity.

Study details: A prospective cohort study (n = 292).

Disclosures: The study received no funding. Dr. Assunção has no financial disclosures.


Assunção H et al. Ann Rheum Dis. 2020;79[suppl 1]:60, Abstract OP0092.